Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
9,159,087,566 shares committed and a 10B MYDX AS.
Company diluted over half a BILLION shares in two weeks.
Santa Yaz going to deliver a reverse split soon.
LOL, so there is no pen.....
MyDx plans to develop additional smart hardware that gather user data, such as the Eco Smart Pen.
LOL....MYDX OS is now 5,901,262,090, exploding from 5,235,755,336 shares just two weeks earlier.
“Clinical Trials for its pain management solution will begin on or around March of 2018, and should be completed by Q3 2018, with periodic updates on the status of results leading up to the completion of trials.”
“The ECO Smart Pen is due out in the second half of 2017.”
“The EcoSmartPen is projected to be shipped in the first quarter.” [of 2018]
“AeroDx is also being programmed to test Cannabis oil for residual solvents. It is currently in beta stage testing and slated for launch in the first half of 2017.”
Are you referring to when Slimpen was supposed to launch the MYDX Pen on July 18, 2018, August 17, 2019 or September 18, 2019?
I’m starting to think Bluetooth optimization might not propel MYDX to NASDAQ.
Maybe some more YouTube views will do it.
One trading day late, but $1.50 has already come and gone.
Next support level test is ~$1.02.
If that support goes, I shudder to think what will happen.
I see your point whether on fifth day or after. I think it's due on the fifth day...45 days from September 30 is November 14, hence calculation to tomorrow.
The 10-Q NT grants MYDX until tomorrow to file its Q3 2019 10-Q on-time.
The MYDX OS is 5,235,755,336 (as of 10/31/19).
The CEO owns at least 2B of those, as restricted shares. Who know how many more though trusts he manages and his consulting company.
Plus, as the company has been saying for a year now, it doesn't have enough shares to pay the bills.
Nobody is buying up MYDX shares.
MYDX has been sued more times by vendors than it has released products.
There may be a small goose in the SP today, but I don't see it lasting.....nearly everything else in the sector is red today.
KSHB issues are more than just the Chinese tariffs, those simply exposed KSHB's issues quicker.
Company lost $40M in FY2019, it has just under $4M in cash. September's bought-deal financing brought in $27.6M (and who knows how much of that is left), and has $58M of debt.
Company needs to spend in order to expand....that bought-deal financing money and the $50M credit is going to go faster than the backstage buffet at a Lizzo show.
I think this is going to reach the ~$1.05 support level established in Spring 2017 before it gets better.
NT-10Q will tell us
$1,539 in product revenue in the first half of 2019. LOL
One of the first things I’m going to look for in the next Q is whether Yazbeck still says the pen is due out Q1 2019.....LOL.
Get away with what?
KSHB has been affected drastically by the Chinese tariffs (since addressed), and internal shitty accounting. Other things as well too long to mention.
Many of the big boys in the sector have been affected by Canadian issues, such as stores in the largest Canadian province of Ontario, being opened on a limited basis.
Separate issues, but the KSHB issues are mostly them shooting their own foot.
And OrganaDX, “coming soon” since 2015.
Okay, that makes sense....thanks.
Rockwell was originally a ~$45K debt, thought fees and associated costs might have come to the final judgment against MYDX....
Judgment was entered as follows: Judgment entered for Cedar Business Services LLC and against CDX Inc. A DELAWARE CORPORATION for $ 55053.00, punitive damages: $ 0.00, attorney fees: $ 1991.59, interest: $ 11725.73, prejudgment costs: $ 565.00, other costs: $ 0.00, amount payable to court: $ .00, for a grand total of $ 69335.32.
Definitely worth reading. Yes, long, but very interesting.
I wonder if that Rockwell debt.....
By late November the Note had balance remaining of $46,527.50 which Rockwell Capital Partners Inc agreed to pay off taking over the debt.
On November 29, 2016, Rockwell Capital Partners Inc included that $46,527.50 in their claim against MYDX in Manatee County court to get the debt turned into discounted free trading stock using the 3(a)10 exemption.
LOL, Yazbeck sued for $29,000,000.00 and settled for $5K.
And he settled to a guy who, according to the court website, had zero legal representation.
Sometimes MYDX slows down dilution in advance of a K or Q filing, then lets it rip after the filing. Presumably because few know about the monthly TA reports that show the OS.
Agreed, hopefully the SEC will be investigating MYDX soon.
Time for consumers to hold companies accountable
It’s all hype from the company until it produces the products it says it will.
The pen has been “coming soon” for over two and a half years and OrganaDX “coming soon” since 2015.
MYDX has been sued for vendor non-payment more times than it has released actual products.
You were right. It’s really an early Christmas miracle that MYDX filed ANYTHING in a timely manner.
Maybe Yazbeck finally realizes that in order to get those 2B restricted shares converted to unrestricted, he’s gotta file stuff on time for an extended period of time.
Can’t wait to see how much “G&A” and “R&D” “expenses” were accrued in Q3.
MYDX 10-Q due today. Will Yazbeck file it or even an NT today?
That’s not dismissed according to the 10Q
And $4.80 to knock the MYDX SP back down 50%.
20k @ .00014 and 20k @ .0001
Ouch.
Ur 150 will be hit by today or tomorrow.
May just sell more to kick it there lol.
Scam garbage..
Now it's said that there actually was a lawsuit.
PLNHF will report AH on Monday, November 25th. Conference call following morning.
Reporting and having call on US Thanksgiving week isn't a good sign.
"Shorting jackasses" are nothing new to the sector or any company.
In fact, short volume on PLNHF has been rather thin in the past couple of weeks, averaging around 40%.
I'm eager to see in the Q if the pen's ETA is still Q1 2019. LOL
MYDX 10-Q due tomorrow. Will the company actually file the Q, NT or just let the SEC deadline pass and become delinquent again?
The financial reports the company itself releases to the SEC does all the damage to MYDX.
When a company goes from a 21M OS to 5,235,755,336 shares and blows through $40M with only one product that is licensed from a third party to show for it, it’s no wonder MYDX has gone from a SP of $3.00 to $0.0001, and has traded in the quads.
MYDX has been sued more times by vendors for non-payment than it has released products.
Clarity being required in order to figure out which lawsuit MYDX is a defendant to says a lot about the company.
Clinical Trials for its pain management solution will begin on or around March of 2018, and should be completed by Q3 2018, with periodic updates on the status of results leading up to the completion of trials.
I smell $1 by end of next week.